Basic and Clinical Research on Renal Cell Carcinoma

  • Gerd Staehler
  • Sigmund Pomer

Table of contents

  1. Front Matter
    Pages I-XII
  2. Molecular and Cellular Basis of Renal Cell Carcinoma

    1. Front Matter
      Pages 1-1
    2. P. Bannasch, H. Zerban
      Pages 9-26
    3. H. Brauch, K. Tory, S. Hosoe, P. Anglard, M. Lerman, M. Linehan et al.
      Pages 27-34
  3. Cell Proliferation and Cellular Heterogeneity in Renal Cell Carcinoma

    1. Front Matter
      Pages 35-35
    2. F. Steinbach, M. Stöckle, J. W. Thüroff, S. Störkel, S. W. Melchior, S. C. Müller et al.
      Pages 49-60
    3. W. de Riese, E. P. Allhoff, C. G. Stief, R. Schlick, P. Anton, U. Jonas
      Pages 61-67
  4. Chemotherapy of Renal Cell Carcinoma

  5. Immunobiology of Renal Cell Carcinoma

    1. Front Matter
      Pages 113-113
    2. A. J. M. C. Beniers, W. P. Peelen, F. M. J. Debruyne, J. A. Schalken
      Pages 121-133
    3. P. Fischer, R. P. Baum, M. Tauber, W. Boeckmann, S. Störkel, S. Weier et al.
      Pages 148-155
    4. J. van Dijk, S. Th. Zegveld, J. D. H. van Eendenburg, E. Braakman, G. J. Fleuren, R. L. H. Bolhuis et al.
      Pages 156-161
  6. Immunotherapy of Renal Cell Carcinoma

  7. Back Matter
    Pages 235-237

About these proceedings


Advanced Renal Cell Carcinoma (RCC) cannot be cured by surgery alone. Its resillience to irradiation and chemotherapy demands a new approach to the management of this disease. This book provides an overview of the scientific and clinical developments of RCC, and clarifies the fields ofimmunotherapy and immunobiology. The book contains a compilation of approaches that will enhance the effectiveness of the management of advancedRCC, even in the absence of definitive pre-clinical data. These require additional study and will stimulate the reassessment of preliminary results.Furthermore, preliminary results of already implemented clinical trials withbiological modifiers are presented. Of special interest are the current achievements in the field of immunotherapy using topically and subcutaneously low dosage combinations of cytokines. This concise volume will benefit those seeking a thorough review of the research and the clinical aspects of RCC simultaneously.


Chemotherapie Immunotherapie Nierenzellkarzinom carcinoma klinische forschung surgery

Editors and affiliations

  • Gerd Staehler
    • 1
  • Sigmund Pomer
    • 1
  1. 1.Abteilung Urologie und Poliklinik KlinikumRuprecht-Karls-UniversitätHeidelbergGermany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1992
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-76865-1
  • Online ISBN 978-3-642-76863-7
  • Buy this book on publisher's site